Q4 2026 Medicare Payment Limit for J9318, effective October 1, 2026: $32.864 per HCPCS billing unit. CMS publishes none for Q3 2026. From CMS's final file.
Drug & Product Overview
About ROMIDEPSIN
Romidepsin is a medication aligned to the HCPCS J Code: J9318 for billing, pricing, and reimbursement purposes in the United States. This Oncology medication is administered via the intravenous route and manufactured by Amneal Biosciences.
According to CMS Drug Use Information: Romidepsin is used to treat a certain type of cancer (cutaneous T-cell lymphoma). Romidepsin works by stopping the growth of cancer cells.
Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.
NDC Code Information
Based on publicly available CMS files. The list of NDCs below is not exhaustive.
| NDC Code | Package | Manufacturer | HCPCS Units | WAC | AWP |
|---|---|---|---|---|---|
| 70121-2250-01 | 27.5 MG / 5.5 MLRomidepsin Intravenous Injection 27.5 MG/5.5ML - 1 VIAL in 1 CARTON (70121-2250-1) / 5.5 mL in 1 VIAL | Amneal Pharmaceuticals LLC | 275 | $8,700.00 $31.636 / unit | $10,440.00 $37.964 / unit |
Effective 6/10/26 (WAC & AWP)
ROMIDEPSIN Pricing & Reimbursement
National median reimbursement across major commercial payers.
Create an account on PayerPrice for more information →Historical Graphing and Billing Calculator
Estimates only. Payer reimbursement varies by contract, site of care, and sequestration.
ROMIDEPSIN CPT Administration Codes
The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.
| CPT Code | Description |
|---|---|
| 96413 | Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug |
| 96415 | Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure) |
CMS has identified Romidepsin (J9318) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. Wastage billing guide →
ROMIDEPSIN Medically Unlikely Edits (MUE)
The most billing units of J9318 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 0.1 mg.
MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →
ROMIDEPSIN Clinical Information
Indications and drug classification.
This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.
Login for BuyandBill.com Analytics
Unlock deeper insights with BuyandBill’s Comparative Report!
- Compare ASP, WAC, and AWP across drugs.
- Visualize Drug Price Movement Over Time
- Tailor reports to drug class, manufacturer, or HCPCS Code.
- Compare Biosimilar and 505(b)(2) products.
Frequently Asked Questions
Is there an available Romidepsin billing and coding guide?
Are there any available Romidepsin patient assistance programs?
Where can I find Romidepsin prescribing information?
Where can I find Romidepsin side effect information?
Does billing ROMIDEPSIN require JZ/JW wastage modifiers?
About BuyandBill.com:
The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.
Related Drug Codes
Explore billing, coding, and pricing for drugs related to ROMIDEPSIN.